The Solitude Armor Set in Elden Ring’s Shadow of the Erdtree expansion is a hulking armor that not only looks cool but also provides you with some of the best damage negation around. This makes it an incredible choice for tanky builds looking to make t...
After finishing a frustrating boss fight in Funko Fusion against a never-ending stream of baddies in a grocery store, I was finally done with Hot Fuzz’s fourth level. I could move on. A cutscene played but the audio was missing. That happens a lot in t...
What’s better than getting a robot to handle cleaning and mopping your floors? Getting it at a discount, which Amazon is offering on eufy’s X10 Pro Omni Robot Vacuum and Mop for $679.99 shipped. Normally priced at $800 most days, we’ve only tracked fou...
The best-selling game of 2023 was Hogwarts Legacy. Yet, despite that single-player title selling 22 million copies, publisher Warner Bros. Discovery will be pivoting away from single-player AAA console games and toward free-to-play, live service, and m...
Eli Lilly and Company (NYSE: LLY) can become the first biopharma company to reach the $1 trillion valuation threshold, courtesy of an under-trial orally administered GLP-1 drug, Orforglipron, as per the latest investment note from Morgan Stanley. $LLY Eli Lilly Has Upside, May Reach $1 Trillion, Says Morgan Stanley (Bloomberg) - PT raised to a Street-high $950 from $805; shares closed at $757.78 on Thursday pic.twitter.com/0LgV0KfrLv — Christian Fromhertz 🇺🇸 (@cfromhertz) February 16, 2024 To wit, Morgan Stanley's Terence Flynn sees Orforglipron's phase three trial results, due in 2025, as a key catalyst for Eli Lilly and Company, paving the […]
With the New Year finally with us, investment bank Morgan Stanley is out with its fresh note for the Taiwan Semiconductor Manufacturing Company (NYSE:TSM), according to a report in the Taiwanese publication United Daily News (UDN). TSMC is the world's largest contract chip manufacturer, competing head to head with Intel and Samsung for manufacturing chips with the latest technologies. The industry's incessant drive to reduce semiconductor feature sizes by as much as technologically feasible has limited manufacturing options to expensive high end machines in scarce supply. These machines, called EUV equipment, will prove key to TSMC unlocking more market share […]
Nintendo has officially announced that it is suing PocketPair, the creators of Palworld, in collaboration with The Pokemon Company. In a statement on NintendoCoLtd on X, Nintendo filed a patent infringement lawsuit in the Tokyo District Court on September 18, 2024. This lawsuit aims to seek an injunction against infringement and damages after PocketPair allegedly infringed multiple patents in Palworld. This news isn't surprising, except that it didn't come sooner. Palworld was first released in January 2024. In the game, there are plenty of "Pals" that look incredibly similar to the creatures in Pokemon, to the point that it's bordering […]
The Serpent Crest Shield is a Medium Shield added in Elden Ring’s Shadow of the Erdtree expansion. It’s an excellent choice for those seeking full physical blocking abilities without being weighed down by one of the game’s massive Greatshields. We high...
The best-selling game of 2023 was Hogwarts Legacy. Yet, despite that single-player title selling 22 million copies, publisher Warner Bros. Discovery will be pivoting away from single-player AAA console games and toward free-to-play, live service, and m...
Eli Lilly and Company (NYSE: LLY) can become the first biopharma company to reach the $1 trillion valuation threshold, courtesy of an under-trial orally administered GLP-1 drug, Orforglipron, as per the latest investment note from Morgan Stanley. $LLY Eli Lilly Has Upside, May Reach $1 Trillion, Says Morgan Stanley (Bloomberg) - PT raised to a Street-high $950 from $805; shares closed at $757.78 on Thursday pic.twitter.com/0LgV0KfrLv — Christian Fromhertz 🇺🇸 (@cfromhertz) February 16, 2024 To wit, Morgan Stanley's Terence Flynn sees Orforglipron's phase three trial results, due in 2025, as a key catalyst for Eli Lilly and Company, paving the […]
With the New Year finally with us, investment bank Morgan Stanley is out with its fresh note for the Taiwan Semiconductor Manufacturing Company (NYSE:TSM), according to a report in the Taiwanese publication United Daily News (UDN). TSMC is the world's largest contract chip manufacturer, competing head to head with Intel and Samsung for manufacturing chips with the latest technologies. The industry's incessant drive to reduce semiconductor feature sizes by as much as technologically feasible has limited manufacturing options to expensive high end machines in scarce supply. These machines, called EUV equipment, will prove key to TSMC unlocking more market share […]